Zhangjie Shi

Title: Innovations of Zhangjie Shi in Mu Opioid Receptor Ligands

Introduction

Zhangjie Shi is an accomplished inventor based in Chicago, IL (US). He has made significant contributions to the field of therapeutic applications through his innovative work on mu opioid receptor ligands. With a total of 2 patents, his research focuses on novel compounds that have the potential to modulate disease symptoms in various subjects, including mammals and humans.

Latest Patents

Zhangjie Shi's latest patents include groundbreaking methods of use and synthesis for mu opioid receptor ligands. These patents describe novel compounds and compositions that are useful in therapeutic applications. The compounds are designed to modulate disease or disease symptoms in subjects such as humans, dogs, cats, and horses. They exhibit binding affinity with the mu opioid receptor (MOR), making them valuable in the treatment of various conditions.

Career Highlights

Throughout his career, Zhangjie Shi has worked with prestigious institutions, including Harvard College. His research has contributed to advancements in the understanding and application of mu opioid receptor ligands. His innovative approach has garnered attention in the scientific community, highlighting his role as a key inventor in this field.

Collaborations

Zhangjie Shi has collaborated with notable individuals such as Bryce Alden Harrison and Tiffany Malinky Gierasch. These collaborations have further enriched his research and contributed to the development of his patented innovations.

Conclusion

Zhangjie Shi's work on mu opioid receptor ligands represents a significant advancement in therapeutic applications. His innovative compounds have the potential to improve the treatment of various diseases, showcasing his impact as an inventor in the field.